286 related articles for article (PubMed ID: 26518612)
1. Systematic review on the use of anticholinergic scales in poly pathological patients.
Villalba-Moreno AM; Alfaro-Lara ER; Pérez-Guerrero MC; Nieto-Martín MD; Santos-Ramos B
Arch Gerontol Geriatr; 2016; 62():1-8. PubMed ID: 26518612
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review.
Salahudeen MS; Duffull SB; Nishtala PS
BMC Geriatr; 2015 Mar; 15():31. PubMed ID: 25879993
[TBL] [Abstract][Full Text] [Related]
3. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
Hsu WH; Wen YW; Chen LK; Hsiao FY
Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
[TBL] [Abstract][Full Text] [Related]
4. A review of published anticholinergic scales and measures and their applicability in database analyses.
Lozano-Ortega G; Johnston KM; Cheung A; Wagg A; Campbell NL; Dmochowski RR; Ng DB
Arch Gerontol Geriatr; 2020; 87():103885. PubMed ID: 31155228
[TBL] [Abstract][Full Text] [Related]
5. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
[TBL] [Abstract][Full Text] [Related]
6. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.
Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C
J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438
[TBL] [Abstract][Full Text] [Related]
7. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis.
Ruxton K; Woodman RJ; Mangoni AA
Br J Clin Pharmacol; 2015 Aug; 80(2):209-20. PubMed ID: 25735839
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews.
Welsh TJ; van der Wardt V; Ojo G; Gordon AL; Gladman JRF
Drugs Aging; 2018 Jun; 35(6):523-538. PubMed ID: 29736815
[TBL] [Abstract][Full Text] [Related]
9. Expert-based drug lists to measure anticholinergic burden: similar names, different results.
Lertxundi U; Domingo-Echaburu S; Hernandez R; Peral J; Medrano J
Psychogeriatrics; 2013 Mar; 13(1):17-24. PubMed ID: 23551407
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anticholinergic burden of medications in older adults.
West T; Pruchnicki MC; Porter K; Emptage R
J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
[TBL] [Abstract][Full Text] [Related]
11. Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.
Hanlon P; Quinn TJ; Gallacher KI; Myint PK; Jani BD; Nicholl BI; Lowrie R; Soiza RL; Neal SR; Lee D; Mair FS
Ann Fam Med; 2020 Mar; 18(2):148-155. PubMed ID: 32152019
[TBL] [Abstract][Full Text] [Related]
12. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
[TBL] [Abstract][Full Text] [Related]
13. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.
Lisibach A; Benelli V; Ceppi MG; Waldner-Knogler K; Csajka C; Lutters M
Eur J Clin Pharmacol; 2021 Feb; 77(2):147-162. PubMed ID: 33011824
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the 'Oldest Old': A Systematic Review of the Literature.
Cardwell K; Hughes CM; Ryan C
Drugs Aging; 2015 Oct; 32(10):835-48. PubMed ID: 26442862
[TBL] [Abstract][Full Text] [Related]
15. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
[TBL] [Abstract][Full Text] [Related]
16. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation.
Koshoedo S; Soiza RL; Purkayastha R; Mangoni AA
Am J Geriatr Pharmacother; 2012 Aug; 10(4):251-7. PubMed ID: 22795433
[TBL] [Abstract][Full Text] [Related]
18. Concordance Between Anticholinergic Burden Scales.
Naples JG; Marcum ZA; Perera S; Gray SL; Newman AB; Simonsick EM; Yaffe K; Shorr RI; Hanlon JT;
J Am Geriatr Soc; 2015 Oct; 63(10):2120-4. PubMed ID: 26480974
[TBL] [Abstract][Full Text] [Related]
19. Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?
Mayer T; Haefeli WE; Seidling HM
Eur J Clin Pharmacol; 2015 Nov; 71(11):1299-314. PubMed ID: 26350641
[TBL] [Abstract][Full Text] [Related]
20. Anticholinergic Drug Burden and Delirium: A Systematic Review.
Egberts A; Moreno-Gonzalez R; Alan H; Ziere G; Mattace-Raso FUS
J Am Med Dir Assoc; 2021 Jan; 22(1):65-73.e4. PubMed ID: 32703688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
